Key Highlights:

  • Exascale Labs shares fell 12.53% to $4.12 in the regular session on October 23, 2026.
  • Fiscal 2026 revenue rose 111.3% to $14.8 million from $7.0 million.
  • Net loss widened to $12.2 million from $7.7 million, including a $7.4 million fair value charge.
  • Net cash proceeds of about $11.8 million followed the business combination that closed August 27, 2026.
  • The qualified customer pipeline is about $300 million, according to the company.

Post-Debut Slide: Why Is Exascale Labs Down 13% on October 23, 2026?

Exascale Labs (NASDAQ:XLAB) shares fell 12.53% to $4.12 on Friday, October 23, 2026, in the regular session. The company has not announced a catalyst for the decline, and its latest release is the fiscal 2026 results issued on September 28, 2026.

The shares began trading on Nasdaq on August 28, 2026, a day after a business combination closed. A quote page showed a 52-week range of $0.78 to $7.39, which places the current price about 44.2% below the high (calculated).

Exascale Labs runs a software-defined GPU compute platform, including GPU-as-a-service offerings, and is classified as an IT services company. A quote page showed a market capitalization of about $246 million.

Fiscal 2026 Results: How Fast Did Revenue Grow?

For the fiscal year ended June 30, 2026, revenue rose 111.3% to $14.8 million from $7.0 million. Its intelligent computing power service grew 124.0%.

Gross profit was $2.4 million, a margin of 16.3% against 15.8% a year earlier. Operating expenses rose to $7.2 million from $4.2 million, and the loss from operations widened to $4.8 million from $3.0 million.

Net loss was $12.2 million compared with $7.7 million, including a $7.4 million change in the fair value of simple agreements for future equity. The financial statements in the release are marked unaudited.

Balance Sheet and Valuation: What Does the Market Value Imply?

Cash and equivalents were $2.7 million at June 30, 2026, plus $2.2 million held in a dollar-pegged digital token. Total assets were $6.7 million against liabilities of $31.9 million, leaving a shareholders' deficit of $25.2 million.

The simple agreements, carried at a fair value of about $29.1 million, converted into Class A common stock at closing. The business combination brought net cash proceeds of about $11.8 million.

A market capitalization of about $246 million on $14.8 million of revenue equals roughly 16.6 times sales (calculated). That ratio uses the market value shown on the quote page rather than the $4.12 closing price.

Customers and Pipeline: What Supports the Growth Outlook?

The customer renewal rate was about 68%. The company's chief executive put the qualified customer pipeline at about $300 million, a management estimate rather than signed revenue.

The company also has a non-binding letter of intent with a Taiwan electronics manufacturer and a non-binding memorandum of understanding with EnergyBank. Neither carries a disclosed dollar value, and the release listed no signed contracts with amounts.

For fiscal 2027, the company listed three priorities and no numeric targets. They are expanding GPU-as-a-service capacity in North America, Asia and Europe, commercializing 800 VDC power and cooling products, and monetizing its orchestration software.

What to Watch Next: Can Exascale Labs Convert Its Pipeline Into Contracts?

The October 23, 2026 decline arrives without a stated trigger, and the shares have fallen from a 52-week high of $7.39. A quote page lists first-quarter fiscal 2027 results for December 15, 2026, although the same page says no earnings are scheduled, and the company has not confirmed a date. That report would show whether the non-binding agreements have produced signed revenue.

Shares fell 12.53% to $4.12, and the company has not announced a catalyst for the move.

Revenue rose 111.3% to $14.8 million, and net loss widened to $12.2 million.

Shares began trading on August 28, 2026, after the business combination closed on August 27.